-
The Lancet reports on the clinical results of phase 1/2 of Russia's new crown vaccine
Time of Update: 2020-11-16
Gam-COVID-Vac immunoreactive immune response test results showed that in Phase 2 clinical trials, 85 percent of participants produced IgG antibodies against the new coronavirus S protein binding domain (RBD) 14 days after receiving the first vaccination.
-
Scientists have found the key to "stopping" cancer cells
Time of Update: 2020-11-12
In this tweet, the editor-in-chief shares the first article, an article by scientists at Oxford University and Johns Hopkins University entitled TargetING TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer: Killing certain human breast cancer cells by selectively attacking the core of the cell division mechanism, created new inspiration for us to find drugs that destroy cancer cells without harming healthy cells.
-
Thousands of people have been disqualified from the practice pharmacist's exam
Time of Update: 2020-10-25
the candidate does not meet the registration conditions or does not handle the relevant matters in accordance with the requirements of the qualification examination department (institution), the examination registration shall be invalid and the fees paid shall not be refunded.
-
Treatment of Alzheimer's anti-Tau vaccine starts phase 1b/2a trial
Time of Update: 2020-07-27
Ac Immune SA, a Swiss-based clinical biopharmaceutical company, has announced it will launch a Phase 1b/2a clinical trial of its ACI-35.030 higher dose group of the Alzheimer's vaccine, following enco
-
Analysis of the future development trend of China's aquatic feed industry
Time of Update: 2020-07-24
Introduction: OA show ('918 '); in recent years, the high profit of aquatic feed industry has welcomed numerous small and medium-sized enterprises to join in, but the high profit also has high risk It
-
Overview of global approval of new drugs in December
Time of Update: 2020-01-14
(2020 / 01 / 14) the implementation of new medical insurance product reimbursement restrictions faces great challenges; the three approved drugs and R & D pipelines of SMO inhibitors are summarized; n
-
Why can't scientists solve the crisis of antibiotic resistance alone, and we need economists
Time of Update: 2019-06-06
June 6, 2019 / BIOON / - driven by the widespread use of antibiotics, bacterial infection is becoming more and more resistant to treatment, and the supply channels of new antibiotics are drying up The
-
Who is in charge of ups and downs: China's biomedical industry under the background of great separation and confluence
Time of Update: 2019-05-29
At present, China's biopharmaceutical industry is in the transition period of policy change, power change and quality change The continuous transformation of the new and old kinetic energy of the indu
